On September 13, 2019, the board of directors of Exactus, Inc. (the Company) appointed Vladislav Bobby Yampolsky to serve as its Interim Executive Chairman. Prior to his appointment, Mr. Yampolsky served as a member of the Board. In addition, the Board also appointed the Companys current President, Emiliano Aloi, to serve as the Companys Interim Chief Executive Officer. The appointments were made following the departure of the Companys Chairman and CEO in August 2019, as reported with the Securities and Exchange Commission on August 21, 2019. In addition, on September 13, 2019, Steven Schwartz, a director, was appointed to the Audit, Compensation and Nominating Committees. Mr. Schwartz is considered by the Company to be an independent director.
Panacea Life Sciences Holdings, Inc. is a holding company organized as a plant-based natural health ingredient and product company. It specializes in the development, manufacturing, research, and distribution of products with natural health and wellness market segment for both humans and animals. The Companyâs subsidiary, Panacea Life Sciences, Inc. (PLS) is engaged in the production, distribution, research, and manufacturing of nutraceuticals, cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products. The Company also offers natural remedies within its branded product lines for every aspect of life, including PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life. It also operates 51,000 square foot current good manufacturing practice (cGMP) facility located in Golden, Colorado. The Company, through Panacea Life Sciences Holdings, Inc., manages six retail locations and a distribution center situated in the Tampa, Florida area.
PANACEA LIFE SCIENCES HOLDINGS, INC. 
